COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics

OBJECTIVES: The systemic autoinflammatory diseases are rare conditions; to date, data on coronavirus disease 2019 (COVID-19) infection and vaccination safety are scarce. Agents targeting innate immune pathways have transformed the management of affected patients, and their outcomes are of wider inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Peet, Claire J, Papadopoulou, Charalampia, Sombrito, Bella Ruth M, Wood, Michael R, Lachmann, Helen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397842/
https://www.ncbi.nlm.nih.gov/pubmed/34466775
http://dx.doi.org/10.1093/rap/rkab043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397842/
https://www.ncbi.nlm.nih.gov/pubmed/34466775
http://dx.doi.org/10.1093/rap/rkab043

Ejemplares similares